Africanews on MSN
South Africa gives twice-yearly HIV prevention jab the green light
It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.
Bizcommunity on MSN
New hope for HIV prevention in South Africa with lenacapavir approval
Lenacapavir is a revolutionary long-acting injectable drug that offers six months of protection with just two annual ...
AllAfrica on MSN
South Africa: Lenacapavir - a Game-Changer in South Africa's HIV Prevention Strategy
When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in January this year, we immediately set about finding solutions. Among the most pressing was to ...
AllAfrica on MSN
South Africa: SA Becomes The First African Country to Register the Twice-a-year Anti-HIV Jab — at Record Speed
South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...
By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...
South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting ...
HIV significantly affects sleep, with many affected people living in a state akin to chronic jet lag. A new study with Wits ...
South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...
The South African on MSN
‘Game-changer’ HIV prevention jab gets green light in South Africa
South Africa has become the first country in Africa to approve Lenacapavir, a revolutionary injection designed to prevent HIV.
The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting antiretroviral treatment, as early as March or April 2026.
Len is for HIV-negative people to try and stop them from getting HIV…when you get an injection, the contents of the injection ...
EFF statement on South Africa registering the twice-a-year anti-HIV injection, Lenacapavir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results